Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic african americans with HIV infection

Clinical Infectious Diseases

Volumn 54, Issue 12, 2012, Pages 1747-1755

  Lai, Hong ^a   Gerstenblith, Gary ^a   Fishman, Elliot K ^a   Brinker, Jeffrey ^a   Kickler, Thomas ^a   Tong, Wenjing ^a   Bhatia, Sundeepan ^a   Hong, Tai ^a   Chen, Shaoguang ^a   Li, Ji ^b   Detrick, Barbara ^a   Lai, Shenghan ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AFRICAN AMERICAN; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; VITAMIN D DEFICIENCY;

ADULT; AFRICAN AMERICANS; ASYMPTOMATIC DISEASES; BALTIMORE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84861521226     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis306     Document Type: Article

References (42)

1. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000; 356:1423-30.
2. Walli R, Herfort O, Michl GM, et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS 1998; 12:F167-73. (Pubitemid 28479266)
3. Vergis EN, Paterson DL, Wagener MM, Swindells S, Singh N. Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy. Int J STD AIDS 2001; 12:463-8. (Pubitemid 32656057)
4. Galli M, Ridolfo AL, Adorni F, et al. Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr 2002; 29:21-31. (Pubitemid 34094303)
5. Friis-Møller N, Weber R, Reiss P, et al. Cardiovascular risk factors in HIV patients-association with antiretroviral therapy: results from the DAD study. AIDS 2003; 17:1179-93. (Pubitemid 36667761)
6. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999; 353:2093-9. (Pubitemid 29278477)
7. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349:1993-2004.
8. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003; 348:702-10. (Pubitemid 36237039)
9. Clark LT, Ferdinand KC, Flack JM, et al. Coronary heart disease in African Americans. Heart Dis 2001; 3:97-108. (Pubitemid 33131483)
10. Camargo CA Jr. Vitamin D and cardiovascular disease time for large randomized trials. J Am Coll Cardiol 2011; 58:1442-4.
11. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52:1949-56.
12. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117:503-11.
13. Lai H, Fishman E, Gerstenblith G, et al. Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users. Int J Cardiol 2011 Feb 2. [Epub ahead of print]. PMID:21295360 [PubMed-as supplied by publisher].
14. Harris SS. Does vitamin D deficiency contribute to increased rates of cardiovascular disease and type 2 diabetes in African Americans? Am J Clin Nutr 2011; 93(suppl):1175S-8S.
15. Ersfeld DL, Rao DS, Body JJ, et al. Analytical and clinical validation of the 25(OH) vitamin D assay for the Liaison automated analyzer. Clin Biochem 2004; 37:867-74. (Pubitemid 39209026)
16. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-47. (Pubitemid 28213628)
17. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, 1989, ISBN: 0-471-61553-6.
18. Lai S, Fishman EK, Lai H, et al. Long-term cocaine use and antiretroviral therapy are associated with silent coronary artery disease in African Americans with HIV infection who have no cardiovascular symptoms. Clin Infect Dis 2008; 46:600-10. (Pubitemid 351263503)
19. Meng Q, Lima JAC, Lai H, et al. Coronary artery calcification, atherogenic lipid changes and increased erythrocyte volume in HIV-1 infected participants treated with protease inhibitors. American Heart J 2002; 144:642-8.
20. Meng Q, Lima JAC, Lai H, et al. Use of HIV protease inhibitors Is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr 2002; 30:306-10. (Pubitemid 34774078)
21. Lai S, Lai H, Meng Q, et al. Effect of cocaine use on coronary calcification among black adults in Baltimore. Am J Cardiol 2002; 90:326-8. (Pubitemid 34804572)
22. Meng Q, Lima JAC, Lai H, et al. Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users. Int J Cardiol 2003; 88:191-8. (Pubitemid 36513656)
23. Lai S, Lai H, Celentano DD, et al. Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors. AIDS Patient Care STDS 2003; 17:211-9. (Pubitemid 36583345)
24. Tong W, Lima JAC, Lai H, Celentano DD, Dai S, Lai S. Relation of coronary artery calcium to left ventricular mass in African Americans. Am J Cardiol 2004; 93:490-2. (Pubitemid 38221367)
25. Tong W, Lima JA, Meng Q, Flynn E, Lai S. Long-term cocaine use and cardiac diastolic dysfunction: an echocardiographic study. Int J Cardiol 2004; 97:25-8. (Pubitemid 39178519)
26. Lai S, Lima JAC, Lai H, et al. HIV-1 infection, cocaine, and coronary calcification. Arch Intern Med 2005; 165:690-5. (Pubitemid 40393154)
27. Meng QY, DU JF, Lai H, Lai SH. Coronary artery calcification is associated with atherogenic lipid changes, cardiac dysfunction and morphologic abnormalities in HIV-1 infected black adults. Chin Med J (Engl) 2005; 118:412-4. (Pubitemid 40378578)
28. Ren S, Tong W, Lai H, Osman NF, Pannu H, Lai S. Effect of longterm cocaine use on regional left ventricular function as determined by magnetic resonance imaging. Am J Cardiol 2006; 97:1085-8.
29. Lai S, Bartlett J, Lai H, et al. Long-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infection. AIDS Patient Care STDs 2009; 23:815-24.
30. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81.
31. Gelfand JM, Cree BA, McElroy J, et al. Vitamin D in African Americans with multiple sclerosis. Neurology 2011; 76:1824-30.
32. Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxy vitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009; 205:255-60.
33. Reddy Vanga S, Good M, Howard PA, Vacek JL. Role of vitamin D in cardiovascular health. Am J Cardiol 2010; 106:798-805. Epub 2010 Aug 1.
34. Tarcin O, Yavuz DG, Ozben B, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009; 94:4023-30.
35. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008; 25: 320-5. (Pubitemid 351322698)
36. Tare M, Emmett SJ, Coleman HA, et al. Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol 2011 Aug 1. [Epub ahead of print].
37. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxy vitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011; 57:63-9. Epub 2010 Nov 29.
38. Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002; 105:546-9. (Pubitemid 34123425)
39. Dayanikli F, Grambow D, Muzik O, Moscan L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994; 90: 808-17. (Pubitemid 24242749)
40. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert HKuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13-ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990; 15: 1032-42. (Pubitemid 20104558)
41. Freedman BI, Wagenknecht LE, Hairston KG, et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 2010; 95:1076-83. Epub 2010 Jan 8.
42. Hollis BW. Short-term and long-term consequences and concerns regarding valid assessment of vitamin D deficiency: comparison of recent food supplementation and clinical guidance reports. Curr Opin Clin Nutr Metab Care 2011; 14:598-604.